Literature DB >> 21030721

CaMKII inhibition in heart failure makes jump to human.

Donald M Bers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21030721     DOI： 10.1161/CIRCRESAHA.110.231902

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  13 in total

1.  The reduced myofilament responsiveness to calcium contributes to the negative force-frequency relationship in rat cardiomyocytes: role of reactive oxygen species and p-38 map kinase.

Authors:  María Sofía Espejo; Ignacio Aiello; Marisa Sepúlveda; Martín G Vila Petroff; Ernesto A Aiello; Verónica C De Giusti
Journal:  Pflugers Arch       Date:  2017-08-23       Impact factor: 3.657

2.  Oxidative activation of Ca(2+)/calmodulin-activated kinase II mediates ER stress-induced cardiac dysfunction and apoptosis.

Authors:  Nathan D Roe; Jun Ren
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-11       Impact factor: 4.733

3.  Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting Ca²⁺/calmodulin-dependent protein kinase II.

Authors:  Zhipeng Meng; Tao Li; Xiaoxiao Ma; Xiaoqiong Wang; Carl Van Ness; Yichao Gan; Hong Zhou; Jinfen Tang; Guiyu Lou; Yafan Wang; Jun Wu; Yun Yen; Rongzhen Xu; Wendong Huang
Journal:  Mol Cancer Ther       Date:  2013-08-19       Impact factor: 6.261

4.  Epac2 mediates cardiac β1-adrenergic-dependent sarcoplasmic reticulum Ca2+ leak and arrhythmia.

Authors:  Laëtitia Pereira; Hongqiang Cheng; Dieu Hung Lao; Li Na; Ralph J van Oort; Joan Heller Brown; Xander H T Wehrens; Ju Chen; Donald M Bers
Journal:  Circulation       Date:  2013-01-30       Impact factor: 29.690

5.  Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling.

Authors:  Lorenz H Lehmann; Julia S Rostosky; Sebastian J Buss; Michael M Kreusser; Jutta Krebs; Walter Mier; Frank Enseleit; Katharina Spiger; Stefan E Hardt; Thomas Wieland; Markus Haass; Thomas F Lüscher; Michael D Schneider; Rosanna Parlato; Hermann-Josef Gröne; Uwe Haberkorn; Masashi Yanagisawa; Hugo A Katus; Johannes Backs
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205

6.  Synthetic phosphopeptides enable quantitation of the content and function of the four phosphorylation states of phospholamban in cardiac muscle.

Authors:  Naa-Adjeley D Ablorh; Xiaoqiong Dong; Zachary M James; Qiang Xiong; Jianyi Zhang; David D Thomas; Christine B Karim
Journal:  J Biol Chem       Date:  2014-09-04       Impact factor: 5.157

Review 7.  Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies.

Authors:  Kwadwo Osei Bonsu; Isaac Kofi Owusu; Kwame Ohene Buabeng; Daniel Diamond Reidpath; Amudha Kadirvelu
Journal:  Ther Clin Risk Manag       Date:  2016-06-03       Impact factor: 2.423

8.  Sex-dependent, zinc-induced dephosphorylation of phospholamban by tissue-nonspecific alkaline phosphatase in the cardiac sarcomere.

Authors:  Yuan Wang; Nicole M Bishop; Douglas J Taatjes; Sonoko Narisawa; José Luis Millán; Bradley M Palmer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-11       Impact factor: 4.733

9.  Chronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure.

Authors:  Yixi Liu; Qun Shao; Heng-Jie Cheng; Tiankai Li; Xiaowei Zhang; Michael F Callahan; David Herrington; Dalane Kitzman; David Zhao; Che-Ping Cheng
Journal:  J Pharmacol Exp Ther       Date:  2021-03-15       Impact factor: 4.402

Review 10.  Gap junction modulation and its implications for heart function.

Authors:  Stefan Kurtenbach; Sarah Kurtenbach; Georg Zoidl
Journal:  Front Physiol       Date:  2014-02-27       Impact factor: 4.566
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.